Reliance Foundation, University of Chicago join hands

Partnership will develop innovative training technology for doctors

Image
BS Reporter Mumbai
Last Updated : Sep 05 2014 | 1:38 AM IST
Reliance Foundation, the philanthropic arm of Reliance Industries, India’s largest private-sector company, and the University of Chicago have announced a collaboration to develop innovative technology that will help train medical students and clinicians for better diagnosis and improved healthcare.

The partnership will develop cloud-based software applications that can train medical professionals using case studies written by experienced physicians and state-of-the-art clinical reasoning methods, RIL said in a statement.

The collaboration is also supporting doctors in real time with evidence-based clinical decision-making tools.

Also Read

“Provided through technology partners i-Human Patients, Inc. and AgileMD, the software will help improve medical education and provide point-of-care clinical decision support tools for healthcare practitioners. These tools will help reduce diagnostic errors, improve outcomes and help save many lives,” RIL said.

The programme will be piloted in Reliance Foundation’s Sir HN Reliance Foundation Hospital and Research Centre in Mumbai.

“Through this collaboration, we look forward to bringing in a technology-based revolution in providing medical education and equipping healthcare professionals to achieve greater standards of excellence," Jagannatha Kumar, CEO, Reliance Foundation said.

Faculty members of the University of Chicago Medicine, led by Scott Stern, MD, have developed the symptom to diagnosis clinical reasoning methodology.

This evidence-based approach to clinical reasoning forms the foundation for the clinical education and point-of-care products being developed in collaboration with Reliance Foundation. Stern will lead the case development team made up of leading medical educators from the US and India.

Dr Vinay Kumar, Donald N. Pritzker Professor and Chairman of Department of Pathology at the University of Chicago said: “We have developed this evidence-based program which, with the power of technology, can be widely disseminated.”
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 05 2014 | 12:36 AM IST

Next Story